These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27957751)

  • 1. Onychomadesis caused by efinaconazole.
    Yamaguchi Y; Hoshina D; Furuya K
    Contact Dermatitis; 2017 Jan; 76(1):57-58. PubMed ID: 27957751
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis caused by efinaconazole: positive patch test reactions up to 0.1% pet.
    Oiso N; Tatebayashi M; Kawada A
    Contact Dermatitis; 2017 Jan; 76(1):53-54. PubMed ID: 27957750
    [No Abstract]   [Full Text] [Related]  

  • 3. Contact dermatitis caused by efinaconazole solution for treatment of onychomycosis.
    Hirohata A; Hanafusa T; Mabuchi-Kiyohara E; Ikegami R
    Contact Dermatitis; 2015 Sep; 73(3):190-2. PubMed ID: 25960269
    [No Abstract]   [Full Text] [Related]  

  • 4. Is tioconazole contact dermatitis still a concern? Bringing allergic contact dermatitis caused by topical tioconazole back into the spotlight.
    Pérez-Mesonero R; Schneller-Pavelescu L; Ochando-Ibernón G; Vergara-Sánchez A; Sánchez-Herreros C; Martín-Alcalde E; Gatica-Ortega ME; Silvestre-Salvador JF; Pastor-Nieto MA
    Contact Dermatitis; 2019 Mar; 80(3):168-169. PubMed ID: 30411354
    [No Abstract]   [Full Text] [Related]  

  • 5. Allergic contact dermatitis caused by undecylenic acid in an antifungal nail solution.
    Ochando-Ibernón G; Schneller-Pavelescu L; Vergara de Caso EF; Silvestre-Salvador JF
    Contact Dermatitis; 2019 May; 80(5):313-314. PubMed ID: 30537336
    [No Abstract]   [Full Text] [Related]  

  • 6. Contact Dermatitis Caused by Efinaconazole and Luliconazole.
    Fujimoto K; Yamaguchi H; Otsuka Y; Mayumi N; Saeki H
    J Nippon Med Sch; 2021 Jun; 88(3):253-257. PubMed ID: 32863343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efinaconazole 10% topical solution for the topical treatment of onychomycosis of the toenail.
    Lipner SR; Scher RK
    Expert Rev Clin Pharmacol; 2015; 8(6):719-31. PubMed ID: 26325488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Onycholysis from nail lacquer: a complication of nail enhancement?
    Guin JD; Wilson P
    Am J Contact Dermat; 1999 Mar; 10(1):34-6. PubMed ID: 10072337
    [No Abstract]   [Full Text] [Related]  

  • 9. Efinaconazole topical solution, 10%: the development of a new topical treatment for toenail onychomycosis.
    Pollak RA
    J Am Podiatr Med Assoc; 2014 Nov; 104(6):568-73. PubMed ID: 25514267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of efinaconazole 10% solution for treatment of mild to moderate onychomycosis: a pooled analysis of two phase 3 randomized trials.
    Gupta AK; Elewski BE; Sugarman JL; Ieda C; Kawabata H; Kang R; Pillai R; Olin JT; Watanabe S
    J Drugs Dermatol; 2014 Jul; 13(7):815-20. PubMed ID: 25007364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efinaconazole topical solution, 10%: formulation development program of a new topical treatment of toenail onychomycosis.
    Bhatt V; Pillai R
    J Pharm Sci; 2015 Jul; 104(7):2177-82. PubMed ID: 25940933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transungual delivery of efinaconazole: its deposition in the nail of onychomycosis patients and in vitro fungicidal activity in human nails.
    Sakamoto M; Sugimoto N; Kawabata H; Yamakawa E; Kodera N; Pillai R; Tatsumi Y
    J Drugs Dermatol; 2014 Nov; 13(11):1388-92. PubMed ID: 25607707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic contact dermatitis due to lanoconazole with no cross-reactivity to other imidazoles.
    Taniguchi S; Kono T
    Dermatology; 1998; 196(3):366. PubMed ID: 9621155
    [No Abstract]   [Full Text] [Related]  

  • 14. Efinaconazole topical, 10% for the treatment of toenail onychomycosis in patients with diabetes.
    Vlahovic TC; Joseph WS
    J Drugs Dermatol; 2014 Oct; 13(10):1186-90. PubMed ID: 25607552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of gender as a clinically relevant outcome variable in the treatment of onychomycosis with efinaconazole topical solution 10.
    Rosen T
    Cutis; 2015 Sep; 96(3):197-201. PubMed ID: 26562270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergic contact dermatitis caused by amorolfine in a nail lacquer.
    Romita P; Stingeni L; Hansel K; De Prezzo S; Ambrogio F; Bonamonte D; Foti C
    Contact Dermatitis; 2019 Nov; 81(5):407-408. PubMed ID: 31314139
    [No Abstract]   [Full Text] [Related]  

  • 17. Onychomadesis secondary to allergic contact dermatitis to tioconazole contained in a nail lacquer: Description of three cases.
    Romita P; Guarneri F; De Prezzo S; Dimauro D; Ambrogio F; Bonamonte D; Foti C
    Contact Dermatitis; 2020 Apr; 82(4):242-243. PubMed ID: 31800097
    [No Abstract]   [Full Text] [Related]  

  • 18. Efinaconazole topical solution, 10%: the benefits of treating onychomycosis early.
    Rich P
    J Drugs Dermatol; 2015 Jan; 14(1):58-62. PubMed ID: 25607909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allergic contact dermatitis due to 1,3-butylene glycol in medicaments.
    Oiso N; Fukai K; Ishii M
    Contact Dermatitis; 2004 Jul; 51(1):40-1. PubMed ID: 15291838
    [No Abstract]   [Full Text] [Related]  

  • 20. Allergic contact dermatitis from luliconazole.
    Shono M
    Contact Dermatitis; 2007 May; 56(5):296-7. PubMed ID: 17441865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.